RRx-001 clinical trials

Studies by the year they started

10 studies that test it; most in 2015 (3)

Who runs them

Industry 10 · Other 0

EpicentRx, Inc. (10)

Often tested with

Tested in the same studies.

Irinotecan (2) · Cisplatin (1) · Etoposide (1) · Nivolumab (1) · Temozolomide (1)

Studies

Open first, then newest update. How each study uses RRx-001 is read from its arms, and is right about nine times in ten.

Testing it · 10

• RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck CancerActive, not recruitingPhase 2EpicentRx, Inc.NCT05966194Written as RRx-001
• RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)CompletedPhase 2EpicentRx, Inc.NCT02489903Written as RRx-001
• Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral CancersCompletedPhase 2EpicentRx, Inc.NCT03515538Written as RRx-001
• Safety and Pharmacokinetic Study of RRx-001 in Cancer SubjectsCompletedPhase 1EpicentRx, Inc.NCT01359982Written as RRx-001
• RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System TumorsTerminatedPhase 1EpicentRx, Inc.NCT04525014Written as RRx-001
• A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal CancerCompletedPhase 2EpicentRx, Inc.NCT02096354Written as RRx-001
• RRx-001 in Second Line Treatment of Advanced Cholangiocarcinoma Prior to Readministration of First-Line TherapyTerminatedPhase 2EpicentRx, Inc.NCT02452970Written as RRx-001
• RRx-001 in Combination With Irinotecan in Metastatic or Advanced Cancer (PAYLOAD)TerminatedPhase 1EpicentRx, Inc.NCT02801097Written as RRx-001
• A Phase I, Open-Label, Multiple Ascending Dose Study of RRx-001 and NivolumabCompletedPhase 1EpicentRx, Inc.NCT02518958Written as RRx-001
• A Phase 1 Pilot Study of the Subcutaneous (s.c.) Route to Facilitate the Administration of RRx-001TerminatedPhase 1EpicentRx, Inc.NCT02096341Written as RRx-001

Codes

What other systems call RRx-001 · ClinicalTrials.gg INT006209

• MeSH (NLM) C577469RRx-001One source Wikidata
• UNII (FDA) 7RPW6SU9SCNIBROZETONEConfirmed FDA, Wikidata
• Wikidata Q27268765rrx-001Confirmed FDA, Wikidata
• DrugBank DB12060One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.